Search – Page 19 – Indianapolis Business Journal

Home » Search

Articles

EDITORIAL: Lilly picks wisely at tough juncture: Lechleiter well-groomed for top job

December 24, 2007

Lilly picks wisely at tough juncture Lechleiter well-groomed for top job Indianapolis’ business and civic leaders are rightfully worried about Eli Lilly and Co. these days. The entire pharmaceutical industry is under extraordinary pressure, in part because the blockbusters that have been its lifeblood aren’t gushing out of development pipelines anymore. Lilly faces the monstrous task of finding successors to its antipsychotic Zyprexa, whose U.S. and European patents expire in 2011-a milestone that’s expected to send the drug’s sales into…

INVESTING: Holding tight right now might wallop portfolio

December 24, 2007

While the seasons are a lot more predictable than the stock market, the market does go through climatic changes that investors should adjust to. In late September, after the market had been rallying for about six weeks off the August low, I mentioned it would be a good idea to reduce equity to around 40 -cent to 50 percent. In the middle of November, I wrote that it might be smart to reduce that level even more. If you’re still…

Taurel helped Lilly weather Prozac defeat, but he also stumbled

December 24, 2007

When Eli Lilly and Co. CEO Sidney Taurel announced his retirement Dec. 18, he said he was leaving the company in good shape.
And he can cite plenty of evidence to support him. But when Taurel steps down as CEO March 31, he also will leave a legacy
of a languishing stock price and some costly mistakes that some think could have been avoided. “The facts are the facts; I
guess you can’t ignore it. The stock price has been…

New Lilly CEO called analytical, ‘incredibly warm’

December 24, 2007

John C. Lechleiter, whom Eli Lilly and Co.’s board voted to replace Sidney Taurel as CEO, is known for getting things done
and yet also for being good at analysis and relating to people under him. Taurel will step down at the end of March but remain
chairman until the end of 2008.

Taurel passes the baton

December 31, 2007

A new leader will guide the city’s largest company in 2008, with some of the biggest challenges in its history on the horizon.
Eli Lilly and Co. announced Dec. 18 that CEO Sidney Taurel will step down March 31 and will be replaced by President John
C. Lechleiter, who has been the heir apparent for more than two years.

Lilly to cooperate with British investigation

January 2, 2008

Eli Lilly and Co. will hand over documents to a United Kingdom agency that is investigating whether it and two other drugmakers bribed the administration of former Iraqi dictator Saddam Hussein. The U.K.’s Serious Fraud Office has requested documents from locally based Lilly as well as from U.K.-based GlaxoSmithKline and AstraZeneca, according to a Bloomberg […]

Lilly asks FDA to approve blood thinner

January 4, 2008

Indianapolis drug company Eli Lilly and Co. and its development partner met their year-end deadline to submit blood thinner prasugrel for regulatory approval. Lilly and Daiichi Sankyo Co. Ltd. filed for U.S. Food and Drug Administration approval on Dec. 26, they announced today. Prasugrel could be a blockbuster if it successfully supplants the current best-selling […]

Rash of deals saves Gazelle venture-capital fund

January 7, 2008

Back in 1999, investors in Gazelle TechVentures expected a sprint to spectacular profits. Instead, they got a marathon slog.
According to Gazelle Chairman and largest investor Scott Jones, it was like training for a race on a sunny day, then running
it through a blizzard.

Lilly stock shoots up after recommendation

January 7, 2008

Shares of Eli Lilly and Co. jumped more than 4 percent today after a Morgan Stanley analyst upgraded the stock to “equal weight” from “underweight.” After opening at $53.16, the shares rose as high as $54.49; the stock traded near $54.10 early this afternoon. Morgan Stanley broker Jami Rubin said Wall Street’s fears about Lilly […]

Lilly gains once-daily clearance for Cialis

January 8, 2008

The U.S. Food and Drug Administration has approved once-daily use of Cialis, the anti-impotence pill made by Eli Lilly and Co., the Indianapolis drugmaker announced today. The once-daily version is a lower dose designed to allow men to have sex at any time between doses. It already has been available in parts of Europe. Since […]

Lechleiter impresses CNBC pharma reporter

January 11, 2008

Incoming Eli Lilly and Co. CEO John Lechleiter can add another feather to his nice-guy hat. Mike Huckman, who follows the pharmaceutical industry for CNBC, wrote in an online posting this week that he was impressed when he interviewed Lechleiter during an industry gathering Monday. Lechleiter takes over for retiring Lilly CEO Sidney Taurel on […]

Mental health docs tap executive market: Carmel’s Indiana Health Group opens high-end suite

January 14, 2008

Greg Sipes likens the new executiveservices suite he and his partners opened three months ago to a BMW. Its quality is solid, to be sure, but what makes people want to drive it is its look and feel. It’s an apt comparison for the 2,500-square-foot wing of the new offices of Sipes’ behavioral health practice, Indiana Health Group. A set of boardroom-like double doors leads to a waiting room with shiny hardwood floors, dark wood paneling, plush rugs, overstuffed chairs…

City emerging as drug distribution hub: Medco Health Solutions deal latest boon to growing subsector in Indiana’s life sciences development efforts

January 21, 2008

Thanks to a series of major economic development wins, Indianapolis is enjoying a pharmaceutical distribution business hot streak. Life sciences industry leaders hope to keep the sizzle burning in 2008 and beyond. “It’s not something we’re hoping we can do someday. It’s something we’re already doing now,” said BioCrossroads CEO David Johnson. “We’re simply trying to expand the footprint of what we’re doing.” Pharmaceutical logistics has become a big business. According to the Arlington, Va.-based Healthcare Distribution Management Association, U.S….

IU takes statewide approach to life sciences pitch

January 21, 2008

For the last two months, two academics at Indiana University and Purdue University have been discussing how the institutions
can work together to rev up research in medicine and life sciences and, in the process, boost Indiana’s economy.

City to announce Super Bowl point person

January 22, 2008

Indianapolis Mayor Greg Ballard this week plans to name a point person to head the city’s bid for the 2012 Super Bowl. Ballard spokeman Marcus Barlow said today the mayor’s office has moved forward and that other leaders are falling into place. John Lechleiter, who will become CEO of Eli Lilly and Co. in April, […]

$1M Tobias gift to help theater

January 23, 2008

Randall and Marianne Tobias have donated $1 million to the Indianapolis Museum of Art to renovate the museum’s 604-seat namesake theater. The newly polished venue will open this fall and IMA plans to screen films and bring in speakers on topics dear to the museum’s new focus on design and the interaction of art and […]

Miles to lead Super Bowl bid

January 23, 2008

Central Indiana Corporate Partnership CEO Mark Miles will lead the city’s attempt to land the Super Bowl in 2012, according to a source familiar with the matter. The announcement of Miles’ selection is expected this week. The source, who asked not to be named, said Miles will oversee initial research as well as assembling the […]

New Zyprexa lawsuit targets Lilly honchos: Shareholders ask directors, officers to pay company

January 28, 2008

The latest shareholder lawsuit against Eli Lilly and Co. over its drug Zyprexa gets personal. The shareholders blame Lilly’s board and top brass, both past and present, for what they call Lilly’s illegal marketing of Zyprexa. In all, the lawsuit asks 18 directors and officers to pay the company for at least the $1.2 billion it has spent to settle Zyprexa lawsuits and to return all compensation they received during an unspecified period when the marketing took place. They name…

Busy year, no whoppers: Deals were numerous in 2007, but lack of blockbuster holds overall price tag down

January 28, 2008

The Indianapolis area didn’t experience a monster-size business transaction in 2007 like it has in recent years, but that doesn’t mean the deal-makers weren’t busy. IBJ’s annual list of Big Deals tracked more large business transactions involving Indianapolis-area companies than ever before in 2007, even though the total dollar amount of the deals was dramatically lower than the previous year’s. Deals compiled by the Indianapolis Business Journal that closed in 2007 totaled $23.4 billion, well below the $38.5 billion posted…

Lilly profit swells on success of new drugs

January 29, 2008

Eli Lilly and Co. profit grew 10 percent in the fourth quarter, to $986.4 million, on the strength of sales for its newer products. Sales of drugs including Cymbalta, Cialis, Alimta, Byetta and Forteo – all launched this decade – grew 30 percent in the quarter. Total sales grew 16 percent to $5.19 billion. The […]

« Previous 1 … 17 18 19 20 21 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

EDITORIAL: Lilly picks wisely at tough juncture: Lechleiter well-groomed for top job

INVESTING: Holding tight right now might wallop portfolio

Taurel helped Lilly weather Prozac defeat, but he also stumbled

New Lilly CEO called analytical, ‘incredibly warm’

Taurel passes the baton

Lilly to cooperate with British investigation

Lilly asks FDA to approve blood thinner

Rash of deals saves Gazelle venture-capital fund

Lilly stock shoots up after recommendation

Lilly gains once-daily clearance for Cialis

Lechleiter impresses CNBC pharma reporter

Mental health docs tap executive market: Carmel’s Indiana Health Group opens high-end suite

City emerging as drug distribution hub: Medco Health Solutions deal latest boon to growing subsector in Indiana’s life sciences development efforts

IU takes statewide approach to life sciences pitch

City to announce Super Bowl point person

$1M Tobias gift to help theater

Miles to lead Super Bowl bid

New Zyprexa lawsuit targets Lilly honchos: Shareholders ask directors, officers to pay company

Busy year, no whoppers: Deals were numerous in 2007, but lack of blockbuster holds overall price tag down

Lilly profit swells on success of new drugs